GLP-1-话题@MedSci

#GLP-1#

111篇内容 | 3538人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1422709, encodeId=a8661422e0919, content=<a href='/topic/show?id=54fa80e701' target=_blank style='color:#2F92EE;'>#GLP-1#</a>, objectTitle=Diabetologia：GLP-1类似物利西拉肽通过调节巨噬细胞表型降低胰岛素抵抗小鼠的动脉粥样硬化, objectType=article, longId=115002, objectId=5ba011500274, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5ba011500274, replyNumber=0, likeNumber=46, createdTime=2017-10-02, rootId=0, userName=yibei, userId=f8f23732777, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5ba011500274, moduleTitle=Diabetologia：GLP-1类似物利西拉肽通过调节巨噬细胞表型降低胰岛素抵抗小鼠的动脉粥样硬化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5ba011500274)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1422708, encodeId=53a31422e0847, content=<a href='/topic/show?id=54fa80e701' target=_blank style='color:#2F92EE;'>#GLP-1#</a>, objectTitle=Diabetologia：生长抑素在GLP-1诱导的小鼠胰高血糖素分泌抑制中的作用, objectType=article, longId=114995, objectId=3b02114995c7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3b02114995c7, replyNumber=0, likeNumber=72, createdTime=2017-10-02, rootId=0, userName=yibei, userId=f8f23732777, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3b02114995c7, moduleTitle=Diabetologia：生长抑素在GLP-1诱导的小鼠胰高血糖素分泌抑制中的作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3b02114995c7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1422707, encodeId=3e7b1422e0782, content=<a href='/topic/show?id=54fa80e701' target=_blank style='color:#2F92EE;'>#GLP-1#</a>, objectTitle=JCEM：单剂量二甲双胍增强2型糖尿病患者胆汁酸诱导的GLP-1分泌, objectType=article, longId=111632, objectId=9fb711163273, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9fb711163273, replyNumber=0, likeNumber=65, createdTime=2017-09-03, rootId=0, userName=yibei, userId=f8f23732777, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9fb711163273, moduleTitle=JCEM：单剂量二甲双胍增强2型糖尿病患者胆汁酸诱导的GLP-1分泌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9fb711163273)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1422706, encodeId=a50b1422e0615, content=<a href='/topic/show?id=54fa80e701' target=_blank style='color:#2F92EE;'>#GLP-1#</a>, objectTitle=Diabetologia：GLP-1信号传导补偿βIRKO小鼠调节β细胞增殖的胰岛素信号受损, objectType=article, longId=107459, objectId=57e910e45950, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=57e910e45950, replyNumber=0, likeNumber=73, createdTime=2017-08-03, rootId=0, userName=yibei, userId=f8f23732777, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=57e910e45950, moduleTitle=Diabetologia：GLP-1信号传导补偿βIRKO小鼠调节β细胞增殖的胰岛素信号受损, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=57e910e45950)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1422705, encodeId=f7e91422e0537, content=<a href='/topic/show?id=54fa80e701' target=_blank style='color:#2F92EE;'>#GLP-1#</a>, objectTitle=Diabetes Obes Metab：早期2型糖尿病患者使用利拉鲁肽或增强内源性GLP-1分泌应答, objectType=article, longId=98775, objectId=597598e7571, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=597598e7571, replyNumber=0, likeNumber=48, createdTime=2017-05-17, rootId=0, userName=yibei, userId=f8f23732777, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=597598e7571, moduleTitle=Diabetes Obes Metab：早期2型糖尿病患者使用利拉鲁肽或增强内源性GLP-1分泌应答, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=597598e7571)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1422704, encodeId=0e751422e04db, content=<a href='/topic/show?id=54fa80e701' target=_blank style='color:#2F92EE;'>#GLP-1#</a>, objectTitle=FASEB J：糖尿病治疗新进展：双肽PGLP-1有效增强胰岛素敏感性！, objectType=article, longId=98643, objectId=5c23986433d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5c23986433d, replyNumber=0, likeNumber=47, createdTime=2017-05-14, rootId=0, userName=yibei, userId=f8f23732777, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5c23986433d, moduleTitle=FASEB J：糖尿病治疗新进展：双肽PGLP-1有效增强胰岛素敏感性！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5c23986433d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1422703, encodeId=591f1422e031c, content=<a href='/topic/show?id=54fa80e701' target=_blank style='color:#2F92EE;'>#GLP-1#</a>, objectTitle=Diabetes：Neurturin和GLP-1类似物协同作用缓解Zucker糖尿病肥胖大鼠糖尿病！, objectType=article, longId=96123, objectId=b2de961238c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b2de961238c, replyNumber=0, likeNumber=66, createdTime=2017-04-19, rootId=0, userName=yibei, userId=f8f23732777, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b2de961238c, moduleTitle=Diabetes：Neurturin和GLP-1类似物协同作用缓解Zucker糖尿病肥胖大鼠糖尿病！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b2de961238c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1422702, encodeId=aedc1422e02df, content=<a href='/topic/show?id=54fa80e701' target=_blank style='color:#2F92EE;'>#GLP-1#</a>, objectTitle=Diabetes Obes Metab：治疗2型糖尿病众多GLP-1RA排座次, objectType=article, longId=95493, objectId=77e9954938e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=77e9954938e, replyNumber=0, likeNumber=60, createdTime=2017-04-13, rootId=0, userName=yibei, userId=f8f23732777, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=77e9954938e, moduleTitle=Diabetes Obes Metab：治疗2型糖尿病众多GLP-1RA排座次, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=77e9954938e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1422701, encodeId=d3281422e01a1, content=<a href='/topic/show?id=54fa80e701' target=_blank style='color:#2F92EE;'>#GLP-1#</a>, objectTitle=Diabetes Care：GLP-1受体激动剂dulaglutide治疗的胰腺安全评估分析！, objectType=article, longId=91502, objectId=711891502a5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=711891502a5, replyNumber=0, likeNumber=57, createdTime=2017-03-13, rootId=0, userName=yibei, userId=f8f23732777, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=711891502a5, moduleTitle=Diabetes Care：GLP-1受体激动剂dulaglutide治疗的胰腺安全评估分析！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=711891502a5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1422699, encodeId=3a641422699c6, content=<a href='/topic/show?id=54fa80e701' target=_blank style='color:#2F92EE;'>#GLP-1#</a>, objectTitle=EASD 2016：阿斯利康2型糖尿病组合疗法Bydureon/Forxiga（GLP-1RA/SGLT-2i）III期临床显著降低血糖水平、体重、收缩压, objectType=article, longId=78308, objectId=7164e8308d1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7164e8308d1, replyNumber=0, likeNumber=31, createdTime=2016-09-25, rootId=0, userName=yibei, userId=f8f23732777, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7164e8308d1, moduleTitle=EASD 2016：阿斯利康2型糖尿病组合疗法Bydureon/Forxiga（GLP-1RA/SGLT-2i）III期临床显著降低血糖水平、体重、收缩压, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7164e8308d1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1422700, encodeId=71301422e0025, content=<a href='/topic/show?id=54fa80e701' target=_blank style='color:#2F92EE;'>#GLP-1#</a>, objectTitle=EASD 2016：诺和诺德长效GLP-1降糖药semaglutide三大功效：降糖，减肥，降低心血管风险, objectType=article, longId=78310, objectId=11a0e8310ab, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=11a0e8310ab, replyNumber=0, likeNumber=70, createdTime=2016-09-25, rootId=0, userName=yibei, userId=f8f23732777, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=11a0e8310ab, moduleTitle=EASD 2016：诺和诺德长效GLP-1降糖药semaglutide三大功效：降糖，减肥，降低心血管风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=11a0e8310ab)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1422698, encodeId=23d4142269858, content=<a href='/topic/show?id=54fa80e701' target=_blank style='color:#2F92EE;'>#GLP-1#</a>, objectTitle=Clin Nutr：GLP-1和GLP-2调节肠衰竭患儿的肠道适应性, objectType=article, longId=77533, objectId=ed51e75334a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ed51e75334a, replyNumber=0, likeNumber=73, createdTime=2016-09-17, rootId=0, userName=yibei, userId=f8f23732777, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ed51e75334a, moduleTitle=Clin Nutr：GLP-1和GLP-2调节肠衰竭患儿的肠道适应性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ed51e75334a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1422697, encodeId=ef63142269e11, content=<a href='/topic/show?id=54fa80e701' target=_blank style='color:#2F92EE;'>#GLP-1#</a>, objectTitle=JAMA Intern Med：GLP-1类似物会增加胆管和胆囊疾病风险, objectType=article, longId=74513, objectId=a4c4e4513ef, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a4c4e4513ef, replyNumber=0, likeNumber=56, createdTime=2016-08-07, rootId=0, userName=yibei, userId=f8f23732777, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a4c4e4513ef, moduleTitle=JAMA Intern Med：GLP-1类似物会增加胆管和胆囊疾病风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a4c4e4513ef)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1422696, encodeId=28831422696fe, content=<a href='/topic/show?id=54fa80e701' target=_blank style='color:#2F92EE;'>#GLP-1#</a>, objectTitle=Cell子刊综述总结肠分泌激素GLP-1参与的心血管生物学, objectType=article, longId=72298, objectId=e2a5e229887, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e2a5e229887, replyNumber=0, likeNumber=66, createdTime=2016-07-09, rootId=0, userName=yibei, userId=f8f23732777, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e2a5e229887, moduleTitle=Cell子刊综述总结肠分泌激素GLP-1参与的心血管生物学, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e2a5e229887)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1422695, encodeId=279a142269568, content=<a href='/topic/show?id=54fa80e701' target=_blank style='color:#2F92EE;'>#GLP-1#</a>, objectTitle=长效GLP-1降糖药semaglutide显著降低2型糖尿病患者重大心血管事件风险（SUSTAIN 6研究）, objectType=article, longId=67351, objectId=ce4c6e35197, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ce4c6e35197, replyNumber=0, likeNumber=31, createdTime=2016-05-01, rootId=0, userName=yibei, userId=f8f23732777, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ce4c6e35197, moduleTitle=长效GLP-1降糖药semaglutide显著降低2型糖尿病患者重大心血管事件风险（SUSTAIN 6研究）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ce4c6e35197)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1422694, encodeId=0a021422694bf, content=<a href='/topic/show?id=54fa80e701' target=_blank style='color:#2F92EE;'>#GLP-1#</a>, objectTitle=AIM：GLP-1RAs治疗2型糖尿病—受益和损害, objectType=article, longId=60432, objectId=0aae6043274, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0aae6043274, replyNumber=0, likeNumber=71, createdTime=2015-12-10, rootId=0, userName=yibei, userId=f8f23732777, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0aae6043274, moduleTitle=AIM：GLP-1RAs治疗2型糖尿病—受益和损害, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0aae6043274)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1422693, encodeId=1db3142269360, content=<a href='/topic/show?id=54fa80e701' target=_blank style='color:#2F92EE;'>#GLP-1#</a>, objectTitle=NEJM新闻：快讯！每周一次GLP-1RAs，治疗2型糖尿病, objectType=article, longId=60426, objectId=1e26604262f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1e26604262f, replyNumber=0, likeNumber=32, createdTime=2015-12-10, rootId=0, userName=yibei, userId=f8f23732777, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1e26604262f, moduleTitle=NEJM新闻：快讯！每周一次GLP-1RAs，治疗2型糖尿病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1e26604262f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1422692, encodeId=1801142269290, content=<a href='/topic/show?id=54fa80e701' target=_blank style='color:#2F92EE;'>#GLP-1#</a>, objectTitle=Addict Biology： GLP-1样药物可用于治疗酒精依赖症, objectType=article, longId=56667, objectId=2b575666eaf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2b575666eaf, replyNumber=0, likeNumber=0, createdTime=2015-09-29, rootId=0, userName=yibei, userId=f8f23732777, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2b575666eaf, moduleTitle=Addict Biology： GLP-1样药物可用于治疗酒精依赖症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2b575666eaf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1422691, encodeId=a838142269165, content=<a href='/topic/show?id=54fa80e701' target=_blank style='color:#2F92EE;'>#GLP-1#</a>, objectTitle=ADA 2015：GLP-1类药物降低体重的奥秘——影响大脑对食物的反应, objectType=article, longId=51987, objectId=57f45198e5d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=57f45198e5d, replyNumber=0, likeNumber=71, createdTime=2015-06-13, rootId=0, userName=yibei, userId=f8f23732777, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=57f45198e5d, moduleTitle=ADA 2015：GLP-1类药物降低体重的奥秘——影响大脑对食物的反应, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=57f45198e5d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1422690, encodeId=f27d142269083, content=<a href='/topic/show?id=54fa80e701' target=_blank style='color:#2F92EE;'>#GLP-1#</a>, objectTitle=Diabetes：GLP-1五肽小分子可抑制肥胖, objectType=article, longId=49422, objectId=7c7e4942222, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7c7e4942222, replyNumber=0, likeNumber=60, createdTime=2015-04-17, rootId=0, userName=yibei, userId=f8f23732777, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7c7e4942222, moduleTitle=Diabetes：GLP-1五肽小分子可抑制肥胖, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7c7e4942222)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

GLP-1

2020-05-29

yibei (审核中...)

前往app查看评论内容

#GLP-1#

Diabetologia：GLP-1类似物利西拉肽通过调节巨噬细胞表型降低胰岛素抵抗小鼠的动脉粥样硬化

2017-10-02

yibei (审核中...)

前往app查看评论内容

#GLP-1#

Diabetologia：生长抑素在GLP-1诱导的小鼠胰高血糖素分泌抑制中的作用

2017-10-02

yibei (审核中...)

前往app查看评论内容

#GLP-1#

JCEM：单剂量二甲双胍增强2型糖尿病患者胆汁酸诱导的GLP-1分泌

2017-09-03

yibei (审核中...)

前往app查看评论内容

#GLP-1#

Diabetologia：GLP-1信号传导补偿βIRKO小鼠调节β细胞增殖的胰岛素信号受损

2017-08-03

yibei (审核中...)

前往app查看评论内容

#GLP-1#

Diabetes Obes Metab：早期2型糖尿病患者使用利拉鲁肽或增强内源性GLP-1分泌应答

2017-05-17

yibei (审核中...)

前往app查看评论内容

#GLP-1#

FASEB J：糖尿病治疗新进展：双肽PGLP-1有效增强胰岛素敏感性！

2017-05-14

yibei (审核中...)

前往app查看评论内容

#GLP-1#

Diabetes：Neurturin和GLP-1类似物协同作用缓解Zucker糖尿病肥胖大鼠糖尿病！

2017-04-19

yibei (审核中...)

前往app查看评论内容

#GLP-1#

Diabetes Obes Metab：治疗2型糖尿病众多GLP-1RA排座次

2017-04-13

yibei (审核中...)

前往app查看评论内容

#GLP-1#

Diabetes Care：GLP-1受体激动剂dulaglutide治疗的胰腺安全评估分析！

2017-03-13

yibei (审核中...)

前往app查看评论内容

#GLP-1#

EASD 2016：阿斯利康2型糖尿病组合疗法Bydureon/Forxiga（GLP-1RA/SGLT-2i）III期临床显著降低血糖水平、体重、收缩压

2016-09-25

yibei (审核中...)

前往app查看评论内容

#GLP-1#

EASD 2016：诺和诺德长效GLP-1降糖药semaglutide三大功效：降糖，减肥，降低心血管风险

2016-09-25

yibei (审核中...)

前往app查看评论内容

#GLP-1#

Clin Nutr：GLP-1和GLP-2调节肠衰竭患儿的肠道适应性

2016-09-17

yibei (审核中...)

前往app查看评论内容

#GLP-1#

JAMA Intern Med：GLP-1类似物会增加胆管和胆囊疾病风险

2016-08-07

yibei (审核中...)

前往app查看评论内容

#GLP-1#

Cell子刊综述总结肠分泌激素GLP-1参与的心血管生物学

2016-07-09

yibei (审核中...)

前往app查看评论内容

#GLP-1#

长效GLP-1降糖药semaglutide显著降低2型糖尿病患者重大心血管事件风险（SUSTAIN 6研究）

2016-05-01

yibei (审核中...)

前往app查看评论内容

#GLP-1#

AIM：GLP-1RAs治疗2型糖尿病—受益和损害

2015-12-10

yibei (审核中...)

前往app查看评论内容

#GLP-1#

NEJM新闻：快讯！每周一次GLP-1RAs，治疗2型糖尿病

2015-12-10

yibei (审核中...)

前往app查看评论内容

#GLP-1#

Addict Biology： GLP-1样药物可用于治疗酒精依赖症

2015-09-29

yibei (审核中...)

前往app查看评论内容

#GLP-1#

ADA 2015：GLP-1类药物降低体重的奥秘——影响大脑对食物的反应

2015-06-13

yibei (审核中...)

前往app查看评论内容

#GLP-1#

Diabetes：GLP-1五肽小分子可抑制肥胖

2015-04-17

科室
- - 订阅+
  - 更多科室
工具
服务